We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.3B
AUM Growth
-$6.59M
Cap. Flow
+$16.8M
Cap. Flow %
0.73%
Top 10 Hldgs %
40.75%
Holding
312
New
11
Increased
145
Reduced
91
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 11.09%
2 Healthcare 7.74%
3 Financials 4.66%
4 Industrials 4.48%
5 Communication Services 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOTL icon
76
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.1B
$6.93M 0.3%
143,441
-7,721
-5% -$374K
BKLN icon
77
Invesco Senior Loan ETF
BKLN
$6.97B
$6.71M 0.29%
303,411
-4,011
-1% -$88.7K
ABT icon
78
Abbott
ABT
$183B
$6.57M 0.29%
55,638
+122
+0.2% +$15K
CMCSA icon
79
Comcast
CMCSA
$85B
$5.83M 0.25%
104,173
+6,385
+7% +$372K
SCHX icon
80
Schwab US Large- Cap ETF
SCHX
$71.8B
$5.76M 0.25%
332,358
+10,428
+3% +$186K
ETN icon
81
Eaton
ETN
$161B
$5.59M 0.24%
37,447
+355
+1% +$56.7K
SCHE icon
82
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$5.48M 0.24%
179,792
-48,557
-21% -$1.52M
CVS icon
83
CVS Health
CVS
$133B
$5.44M 0.24%
64,134
-110,209
-63% -$9.23M
VEA icon
84
Vanguard FTSE Developed Markets ETF
VEA
$229B
$5.44M 0.24%
107,728
+923
+0.9% +$48K
IWM icon
85
iShares Russell 2000 ETF
IWM
$79.8B
$5.07M 0.22%
23,177
+162
+0.7% +$35.9K
JHMM icon
86
John Hancock Multifactor Mid Cap ETF
JHMM
$5.92B
$4.78M 0.21%
92,548
CVX icon
87
Chevron
CVX
$392B
$4.33M 0.19%
42,729
+1,536
+4% +$153K
LMT icon
88
Lockheed Martin
LMT
$135B
$4.3M 0.19%
12,467
+775
+7% +$280K
PEP icon
89
PepsiCo
PEP
$191B
$4.22M 0.18%
28,068
-1,138
-4% -$176K
IEO icon
90
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
$4.14M 0.18%
71,325
-120
-0.2% -$6.26K
BDX icon
91
Becton Dickinson
BDX
$45.6B
$4.1M 0.18%
17,089
+2,491
+17% +$611K
EEM icon
92
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$4.09M 0.18%
81,178
-2,624
-3% -$137K
XOM icon
93
ExxonMobil
XOM
$644B
$4.08M 0.18%
69,288
-313
-0.4% -$17.8K
AVGO icon
94
Broadcom
AVGO
$1.85T
$4.06M 0.18%
83,770
+2,460
+3% +$120K
BRK.B icon
95
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.03M 0.18%
14,764
-284
-2% -$79.8K
PG icon
96
Procter & Gamble
PG
$337B
$3.95M 0.17%
28,245
+345
+1% +$48.9K
VBK icon
97
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$3.87M 0.17%
13,824
MET icon
98
MetLife
MET
$61.9B
$3.68M 0.16%
59,593
+2,826
+5% +$170K
PFE icon
99
Pfizer
PFE
$143B
$3.48M 0.15%
80,979
-1,097
-1% -$48.6K
VWO icon
100
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.46M 0.15%
69,259
-1,966
-3% -$102K

Similar funds

Grimes & Company's Q3 2021 Portfolio in Review

As of Q3 2021, Grimes & Company held 312 positions worth $2.3B, down 0.29% from $2.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Grimes & Company's Q3 2021 filing shows 11 new, 145 increased, 91 reduced and 11 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 586,638 shares worth $22M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q3 2021 buy was State Street Financial Select Sector SPDR ETF: 586,638 shares worth $22M.
  • Grimes & Company added most to State Street Blackstone Senior Loan ETF in Q3 2021, an estimated $13.4M increase.
  • Grimes & Company's biggest Q3 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $21.3M.
  • Grimes & Company fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2021, selling an estimated $16.6M.
  • Grimes & Company's ten largest holdings make up 41% of its $2.3B portfolio in Q3 2021.
  • Grimes & Company opened 11 new positions and closed 11 in Q3 2021.
  • Grimes & Company's portfolio value fell 0.29% quarter-over-quarter to $2.3B.

Based on Grimes & Company's 13F filing for Q3 2021, filed 8 Nov 2021.